As of Oct 02
| +0.31 / +5.05%|
The 1 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +117.05% increase from the last price of 6.45.
The current consensus among 1 polled investment analysts is to Buy stock in ChemoCentryx Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.